Form 483

Dabur India Limited Form 483, 2026-01-16

FDA issued a Form 483 to Dabur India Limited on 2026-01-16 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

Dabur India Limited · Dadra And Nagar Haveli, India · Issued January 16, 2026

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

16 Jan 2026
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Rafeeq A Habeeb

16 Jan 2026
21 CFR 211.180(e)(1)

Review of representative number of batches

Cited by Rafeeq A Habeeb

16 Jan 2026
21 CFR 211.192

Quality control unit review of records

Cited by Rafeeq A Habeeb

16 Jan 2026
21 CFR 211.22(a)

Authority lacking to review records, investigate errors

Cited by Rafeeq A Habeeb

16 Jan 2026
21 CFR 211.56(a)

Sanitation--buildings not clean, free of infestation

Cited by Rafeeq A Habeeb

Inspected site

DIDabur India LimitedDadra And Nagar Haveli, India

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.56(a)Cited across public-safe Form 483 observations1x
21 CFR 211.65(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)(5)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 7 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere